| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.642 | 1.491 | 2.130 | 3.143 | 7.158 | 5.639 | 5.653 | 5.405 | 7.460 | 9.142 |
| Total Income - EUR | 1.642 | 1.491 | 2.130 | 3.143 | 7.187 | 5.926 | 5.653 | 5.405 | 7.460 | 9.189 |
| Total Expenses - EUR | 2.425 | 3.039 | 7.713 | 7.428 | 6.516 | 4.184 | 3.495 | 5.347 | 10.457 | 11.207 |
| Gross Profit/Loss - EUR | -783 | -1.548 | -5.583 | -4.285 | 671 | 1.742 | 2.158 | 58 | -2.996 | -2.018 |
| Net Profit/Loss - EUR | -833 | -1.577 | -5.604 | -4.316 | 599 | 1.622 | 1.988 | -51 | -3.071 | -2.109 |
| Employees | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Ancamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 124 | 530 | 10 | -30 | 0 | 0 | 440 | 508 | 991 | 407 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 20 | 0 | 0 | 0 | 4 | 221 | 107 | 107 | 0 |
| Cash | 124 | 510 | 10 | -30 | 0 | -5 | 219 | 401 | 884 | 407 |
| Shareholders Funds | -18.416 | -19.806 | -25.075 | -28.931 | -27.772 | -25.624 | -23.067 | -23.190 | -26.191 | -28.154 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 18.540 | 20.335 | 25.085 | 28.901 | 27.772 | 25.623 | 23.507 | 23.698 | 27.181 | 28.560 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9602 - 9602" | |||||||||
| CAEN Financial Year |
9602
|
|||||||||
Comments - Ancamed Srl